Zhang, N., Du, Y., Yu, Y., Wu, Q., Bai, W., Zhang, W., Zhang, S., Yu, H., Liu, X., Luo, M., Liu, K., Hao, J. (2025). Comparison outcome of transarterial chemoembolization combined with immune checkpoint inhibitors plus bevacizumab or lenvatinib as first-line therapy for advanced hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4141